ArticleEClinicalMedicine2023

The cancer premium - explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional study.

Miquel Serra-Burriel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.